On the upside
Imperial Industries (Nasdaq: IPII) extended the terms of its credit facility.
Vical (Nasdaq: VICL) received a new patent for its Vaxfectin-formulated DNA vaccines for seasonal and pandemic flu viruses.
Del Monte Foods (NYSE: DLM) swung to a first quarter profit that topped estimates prompting the company to lift its full year outlook.
On the downside
Amedisys (Nasdaq: AMED) announced that its president and chief operating officer Larry Graham and its chief information technology officer Alice Schwartz both resigned.
Although Hovnanian Enterprises (NYSE: HOV) narrowed its third quarter loss, the results fell short of expectations.
A federal judge rejected a motion to dismiss a class action lawsuit accusing Moody's Corp. (NYSE: MCO) of fraud.
In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by more than 9 to 7 on Nasdaq. The Russell 2000 which tracks small cap stocks added a point to 557.
